毒素A型配方中的辅助剂替代:从多尺度的模拟模型的洞察
Eqram Rahman1, Alain Michon2, Parinitha Rao3
1Research and Innovation Hub, Innovation Aesthetics, London UK.
Journal of pharmaceutical sciences
|December 23, 2025
概括
与人血清白蛋白 (HSA) 结合的三糖显著提高了A型肉毒神经毒素 (BoNT/A) 的稳定性和持续时间. 这种辅助剂组合为开发下一代BoNT/A配方提供了卓越的基础.
科学领域:
- 生物化学 生化学
- 计算化学的计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒神经毒素A型 (BoNT/A) 配方因辅料而异,影响产品的稳定性,聚合和扩散.
- 了解辅助剂的作用对于优化BoNT/A的输送和疗效至关重要.
研究的目的:
- 为了评估辅助剂替代对BoNT/A配方的影响,使用多尺度的in silico建模.
- 确定最佳的辅助剂,以提高BoNT/A的稳定性,聚合抵抗性和持续时间.
主要方法:
- 利用多尺度的模拟 (AesthetiSIMTM) 来评估辅助剂对BoNT/A.的影响.
- 进行了分子动力学模拟,以分析蛋白质骨干稳定性 (RMSD) 和辅助物相互作用 (键,相互作用能量).
- 采用粗粒模拟用于聚合倾向和有限元模拟扩散特征.
主要成果:
- 与砂糖和乳糖相比,三糖表现出优越的结合和相互作用能量.
- 与人血清白蛋白 (HSA) 结合的三糖显示出协同稳定,减少RMSD,并将聚合最小化.
- 三糖-HSA配方预测了最佳的扩散半径,并在重制产品中实现了最长的持续时间 (PRABO, LETYBO).
结论:
- 三素-HSA 持续改善了 BoNT/A 的稳定性,聚合性抵抗性和在分子,中视镜和组织层面的持续时间.
- 这些发现为设计下一代具有增强性能的BoNT/A配方提供了合理的基础.
- 优化溶解 (0.5毫升/100单位) 进一步增强了扩散和持久性.
关键词:
肉毒神经毒素类型a扩散模拟的扩散模型.辅助物质 辅助物质 辅助物质配方的稳定性 配方的稳定性人类血清专素的人类血清专素在模拟中.分子动力学分子动力学蛋白质聚合蛋白质的聚合.复制体积的复制量这种树脂含有三糖.更多相关视频
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.7K
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
16.5K
相关概念视频
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
879
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
879